Through many years of involvement and achievements in the pharmaceutical industry, Skyepharma’s development and manufacturing facility is eminently specialized in Complex Oral Solid Dosage Forms. We have the ability to provide customized solutions to our customers by positioning ourselves as a One-Stop-Shop player and a privileged partner offering a wide range of premium services. Our State-of-the Art CDMO facility close to Lyon (France) provides solutions bringing value to our clients at any stage of a product development lifecycle, from small scale programs up to commercial manufacturing and packaging activities. Our value proposal includes tailored services to clients’ requirements supporting them up to market introduction. For more information on Skyepharma, please visit www.skyepharma.com
| Website | https://www.skyepharma.fr/ |
| Revenue | $136.6 million |
| Employees | 234 (162 on RocketReach) |
| Founded | 1993 |
| Address | 55 Rue du Montmurier, Saint-Quentin-Fallavier, Auvergne-Rhône-Alpes 38070, FR |
| Phone | +44 20 7881 0524 |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Inhalation and oral pharmaceutical product development, Manufacturing, Formulation, Inhalation and oral drug delivery, Supply chain management |
| Competitors | GSK, Bristol Myers Squibb, Amgen, Boehringer Ingelheim, Merck Group, Alcon, Pfizer, PillPack, Aprecia Pharmaceuticals, MediPharm Medical Practice +45 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325412 Companies, NAICS Code 32541 Companies |
Looking for a particular Skyepharma employee's phone or email?
The Skyepharma annual revenue was $136.6 million in 2026.
Sébastien Mas is the CEO of Skyepharma.
162 people are employed at Skyepharma.
Skyepharma is based in Saint-Quentin-Fallavier, Auvergne-Rhône-Alpes.
The NAICS codes for Skyepharma are [325, 3254, 32, 325412, 32541].
The SIC codes for Skyepharma are [28, 283].